Recurrent Large Cell Lung Carcinoma

Known as: Relapsed Large Cell Carcinoma of the Lung, Relapsed Large Cell Carcinoma of Lung, Recurrent Large Cell Carcinoma of Lung

The reemergence of large cell lung carcinoma after a period of remission.

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2003

Gefitinib is a newly developed molecular-target drug with selective inhibitory activity for tyrosine kinase of the epidermal…